TENDYNE™
MITRAL VALVE
REPLACEMENT
TRANSCATHETER MITRAL VALVE
REPLACEMENT (TMVR)

 

Tendyne™ TMVR System is first-in-class technology designed to eliminate Mitral Regurgitation (MR),
offering selected patients with MR (≥ grade 3) a novel option for mitral valve replacement.

REPLACE. RESTORE. LIVE.

Expand the boundaries of MR treatments with Tendyne™: a repositionable and fully retrievable mitral valve replacement device that eliminates MR, improves quality of life,  and reduces Heart Failure (HF) hospitalizations without compromising patients’ safety.
 

FIND OUT MORE ABOUT:

MITRAL REGURGITATION   TREATMENT OPTIONS

CLINICAL DATA

Connext
TV

CONNECT TO THE LATEST
IN STRUCTURAL HEART
THERAPY

Find out more

TV

EuroPCR 2022: Mitral replacement

EuroPCR 2022: Mitral replacement – expanding patient options

EuroPCR 2022: Tendyne™

EuroPCR 2022: Expand your mitral portfolio with Tendyne™

EACTS 2022: Tendyne™ vs on-pump MVR

EACTS 2022 Symposium: When can Tendyne™ TMVR be a relevant substitute for on-pump MVR?

EACTS 2022: SMV repair vs replacement

EACTS 2022 Symposium: Surgical Mitral Valve Repair versus Replacement in the Modern Era of Transcatheter Valve Interventions.

ESC 2022: FMR

ESC 2022: How do I manage my patient with functional mitral regurgitation?

PCRLV 2021: Transcatheter mitral valve replacement

PCRLV 2021: Transcatheter mitral valve replacement: patient selection & hemodynamic stability

EACTS 2021: Transcatheter mitral valve implantation

EACTS 2021: Transcatheter mitral valve implantation: patient selection & medical management

Tendyne™: Animation

Tendyne™ Procedural Animation: Quality Time Secured

© Abbott 2023. All rights reserved. 9-EH-5-14381-01 07-2023

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.